In addition, the proportion of patients in secondary hospitals, prior angina, and COPD was higher in higher SHR patients, whereas aspirin, P2Y12 antagonists, and statins were less likely to be used in these patients. This evidence concerns the gene P2RY12 and chronic obstructive pulmonary disease.